US OptionsDetailed Quotes
VKTX241129P64000
- 10.46
- 0.000.00%
15min DelayTrading Nov 29 13:00 ET
0.00High0.00Low
0.00Open10.46Pre Close0 Volume0 Open Interest64.00Strike Price0.00Turnover0.00%IV-1.13%PremiumNov 29, 2024Expiry Date11.06Intrinsic Value100Multiplier-2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma5.06Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Viking Therapeutics Stock Discussion
I suspect they chose not to present the full safety profile, given that the weight loss results for the 120 mg and 280 mg QM cohorts, in obese non-diabetics (without dose escalations), at week 16 in P2 are consistent with the P1 results (see slide 1). So, it is likely that the 120 mg and 280 mg QM (without dose...
🚀🚀🚀🚀 now all engines firing
lets gooooooo
No comment yet